HU treatment also enhanced leukemogenesis induced by p210 Bcr-Abl, although interestingly, these mice all succumbed to CML-like disease (Figure 7B). The gene discussed is EVPL; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.